FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1490753351> ?p ?o ?g. }

• W1490753351 endingPage "1803" @default.
• W1490753351 startingPage "1796" @default.
• W1490753351 abstract "The incidence of invasive fungal infections (IFIs) in nonneutropenic solid organ transplant patients is increasing. We report our clinical experience with the use of interferon-γ (IFN-γ) immunotherapy in seven renal transplant patients who developed life threatening, disseminated IFIs refractory to conventional antifungal drug therapy. The infections were all microbiologically and histologically proven. The rapid cure of these disseminated infections with exogenous IFN-γ injections was not associated with impaired kidney allograft function despite the use of liposomal amphotericin B in all cases. No clinical toxicity from the IFN-γ immunotherapy was seen and no IFI relapsed during long-term follow-up. Our experience is both uncontrolled and in patients with unpredictable fungal infection-related outcomes. However, compared to standard approaches, the accelerated cure of life threatening, disseminated IFIs with 6 weeks of combination antifungal drug therapy and IFN-γ immunotherapy saved lives, retained allograft function and led to substantial cost savings in this small patient group. The incidence of invasive fungal infections (IFIs) in nonneutropenic solid organ transplant patients is increasing. We report our clinical experience with the use of interferon-γ (IFN-γ) immunotherapy in seven renal transplant patients who developed life threatening, disseminated IFIs refractory to conventional antifungal drug therapy. The infections were all microbiologically and histologically proven. The rapid cure of these disseminated infections with exogenous IFN-γ injections was not associated with impaired kidney allograft function despite the use of liposomal amphotericin B in all cases. No clinical toxicity from the IFN-γ immunotherapy was seen and no IFI relapsed during long-term follow-up. Our experience is both uncontrolled and in patients with unpredictable fungal infection-related outcomes. However, compared to standard approaches, the accelerated cure of life threatening, disseminated IFIs with 6 weeks of combination antifungal drug therapy and IFN-γ immunotherapy saved lives, retained allograft function and led to substantial cost savings in this small patient group." @default.
• W1490753351 created "2016-06-24" @default.
• W1490753351 creator A5002570839 @default.
• W1490753351 creator A5010205794 @default.
• W1490753351 creator A5026173669 @default.
• W1490753351 creator A5026545250 @default.
• W1490753351 creator A5036880594 @default.
• W1490753351 creator A5062803492 @default.
• W1490753351 creator A5082686560 @default.
• W1490753351 date "2010-08-01" @default.
• W1490753351 modified "2023-10-11" @default.
• W1490753351 title "Exogenous Interferon-γ Immunotherapy for Invasive Fungal Infections in Kidney Transplant Patients" @default.
• W1490753351 cites W1510382284 @default.
• W1490753351 cites W1646256271 @default.
• W1490753351 cites W1983427833 @default.
• W1490753351 cites W1983737882 @default.
• W1490753351 cites W1994453026 @default.
• W1490753351 cites W1999336252 @default.
• W1490753351 cites W2003627552 @default.
• W1490753351 cites W2006146908 @default.
• W1490753351 cites W2014557179 @default.
• W1490753351 cites W2017219739 @default.
• W1490753351 cites W2017450929 @default.
• W1490753351 cites W2017853284 @default.
• W1490753351 cites W2023382272 @default.
• W1490753351 cites W2024013109 @default.
• W1490753351 cites W2026298628 @default.
• W1490753351 cites W2028978861 @default.
• W1490753351 cites W2050321416 @default.
• W1490753351 cites W2062905473 @default.
• W1490753351 cites W2084004341 @default.
• W1490753351 cites W2086120627 @default.
• W1490753351 cites W2097554202 @default.
• W1490753351 cites W2101461845 @default.
• W1490753351 cites W2103051735 @default.
• W1490753351 cites W2108374918 @default.
• W1490753351 cites W2110464945 @default.
• W1490753351 cites W2114605201 @default.
• W1490753351 cites W2119229753 @default.
• W1490753351 cites W2124426757 @default.
• W1490753351 cites W2125108598 @default.
• W1490753351 cites W2128246249 @default.
• W1490753351 cites W2128907894 @default.
• W1490753351 cites W2130882795 @default.
• W1490753351 cites W2138062851 @default.
• W1490753351 cites W2140146047 @default.
• W1490753351 cites W2142288396 @default.
• W1490753351 cites W2144543496 @default.
• W1490753351 cites W2154300911 @default.
• W1490753351 cites W2155806737 @default.
• W1490753351 cites W2155923390 @default.
• W1490753351 cites W2158951316 @default.
• W1490753351 cites W2160765050 @default.
• W1490753351 cites W2167902573 @default.
• W1490753351 cites W2317993056 @default.
• W1490753351 cites W4254102874 @default.
• W1490753351 doi "https://doi.org/10.1111/j.1600-6143.2010.03094.x" @default.
• W1490753351 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/20353472" @default.
• W1490753351 hasPublicationYear "2010" @default.
• W1490753351 type Work @default.
• W1490753351 sameAs 1490753351 @default.
• W1490753351 citedByCount "80" @default.
• W1490753351 countsByYear W14907533512012 @default.
• W1490753351 countsByYear W14907533512013 @default.
• W1490753351 countsByYear W14907533512014 @default.
• W1490753351 countsByYear W14907533512015 @default.
• W1490753351 countsByYear W14907533512016 @default.
• W1490753351 countsByYear W14907533512017 @default.
• W1490753351 countsByYear W14907533512018 @default.
• W1490753351 countsByYear W14907533512019 @default.
• W1490753351 countsByYear W14907533512020 @default.
• W1490753351 countsByYear W14907533512021 @default.
• W1490753351 countsByYear W14907533512022 @default.
• W1490753351 countsByYear W14907533512023 @default.
• W1490753351 crossrefType "journal-article" @default.
• W1490753351 hasAuthorship W1490753351A5002570839 @default.
• W1490753351 hasAuthorship W1490753351A5010205794 @default.
• W1490753351 hasAuthorship W1490753351A5026173669 @default.
• W1490753351 hasAuthorship W1490753351A5026545250 @default.
• W1490753351 hasAuthorship W1490753351A5036880594 @default.
• W1490753351 hasAuthorship W1490753351A5062803492 @default.
• W1490753351 hasAuthorship W1490753351A5082686560 @default.
• W1490753351 hasBestOaLocation W14907533511 @default.
• W1490753351 hasConcept C126322002 @default.
• W1490753351 hasConcept C142424586 @default.
• W1490753351 hasConcept C16005928 @default.
• W1490753351 hasConcept C203014093 @default.
• W1490753351 hasConcept C2777701055 @default.
• W1490753351 hasConcept C2779548794 @default.
• W1490753351 hasConcept C2779629538 @default.
• W1490753351 hasConcept C71924100 @default.
• W1490753351 hasConcept C86803240 @default.
• W1490753351 hasConcept C87355193 @default.
• W1490753351 hasConcept C8891405 @default.
• W1490753351 hasConceptScore W1490753351C126322002 @default.
• W1490753351 hasConceptScore W1490753351C142424586 @default.
• W1490753351 hasConceptScore W1490753351C16005928 @default.
• W1490753351 hasConceptScore W1490753351C203014093 @default.

• next